These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8844067)
21. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361 [TBL] [Abstract][Full Text] [Related]
22. Analysis of unstable DNA sequence in FMR1 gene in Polish families with fragile X syndrome. Milewski M; Zygulska M; Bal J; Deelen WH; Obersztyn E; Bocian E; Halley DJ; Horst J; Mazurczak T Acta Biochim Pol; 1996; 43(2):383-8. PubMed ID: 8862184 [TBL] [Abstract][Full Text] [Related]
23. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity? Zhong N; Ye L; Dobkin C; Brown WT Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008 [TBL] [Abstract][Full Text] [Related]
24. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population. Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595 [TBL] [Abstract][Full Text] [Related]
25. Molecular/clinical correlations in females with fragile X. Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077 [TBL] [Abstract][Full Text] [Related]
27. [Neurodevelopmental (fragile X syndrome) and neurodegenerative (tremor/ataxia syndrome) disorders associated to the 'growth' of a gene]. Castro-Volio I; Cuenca-Berger P Rev Neurol; 2005 Apr 1-15; 40(7):431-7. PubMed ID: 15849678 [TBL] [Abstract][Full Text] [Related]
28. Transmitting males and carrier females in fragile X--revisited. Loesch DZ; Hay DA; Mulley J Am J Med Genet; 1994 Jul; 51(4):392-9. PubMed ID: 7943005 [TBL] [Abstract][Full Text] [Related]
29. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome]. Chiurazzi P; Neri G Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822 [TBL] [Abstract][Full Text] [Related]
30. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024 [TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the fragile X syndrome. Knight SJ; Hirst MC; Davies KE Dis Markers; 1992; 10(1):1-5. PubMed ID: 1424438 [TBL] [Abstract][Full Text] [Related]
32. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing. Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806 [TBL] [Abstract][Full Text] [Related]
33. Extended gene diversity at the FMR1 locus and neighbouring CA repeats in a sub-Saharan population. Chiurazzi P; Destro-Bisol G; Genuardi M; Oostra BA; Spedini G; Neri G Am J Med Genet; 1996 Jul; 64(1):216-9. PubMed ID: 8826479 [TBL] [Abstract][Full Text] [Related]
34. Neurobehavioral phenotype in carriers of the fragile X premutation. Johnston C; Eliez S; Dyer-Friedman J; Hessl D; Glaser B; Blasey C; Taylor A; Reiss A Am J Med Genet; 2001 Nov; 103(4):314-9. PubMed ID: 11746012 [TBL] [Abstract][Full Text] [Related]
35. Fragile X syndrome without CCG amplification has an FMR1 deletion. Gedeon AK; Baker E; Robinson H; Partington MW; Gross B; Manca A; Korn B; Poustka A; Yu S; Sutherland GR Nat Genet; 1992 Aug; 1(5):341-4. PubMed ID: 1302032 [TBL] [Abstract][Full Text] [Related]
36. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males. Barros Santos C; Gonçalves Pimentel MM Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656 [TBL] [Abstract][Full Text] [Related]
37. Prenatal diagnosis and carrier screening for fragile X by PCR. Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474 [TBL] [Abstract][Full Text] [Related]
38. Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus. Syrrou M; Patsalis PC; Georgiou I; Hadjimarcou MI; Constantinou-Deltas CD; Pagoulatos G Am J Med Genet; 1996 Jul; 64(1):234-8. PubMed ID: 8826482 [TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of 53 fragile X families with the probe StB12.3. Puissant H; Malinge MC; Larget-Piet A; Martin D; Chauveau P; Odent S; Plessis G; Parent P; Lemarec B; Larget-Piet L Am J Med Genet; 1994 Dec; 53(4):370-3. PubMed ID: 7864047 [TBL] [Abstract][Full Text] [Related]
40. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families. Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]